Convalescent plasma therapy in patients with COVID-19.
作者信息
Altuntas Fevzi, Yigenoglu Tugce Nur, Bascı Semih, Dal Mehmet Sinan, Korkmaz Serdal, Turgut Burhan, Erkurt Mehmet Ali
机构信息
University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey; Yıldırım Beyazıt University, School of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey.
University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey.
出版信息
Transfus Apher Sci. 2021 Feb;60(1):103017. doi: 10.1016/j.transci.2020.103017. Epub 2020 Nov 19.
Abstract
摘要
相似文献
1
Convalescent plasma therapy in patients with COVID-19.新型冠状病毒肺炎患者的恢复期血浆治疗
Transfus Apher Sci. 2021 Feb;60(1):103017. doi: 10.1016/j.transci.2020.103017. Epub 2020 Nov 19.
2
Convalescent plasma for COVID-19 considerations.关于新冠病毒病恢复期血浆的考量
Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27.
3
Convalescent plasma (CP) therapy in patients with COVID-19.新冠病毒病患者的恢复期血浆疗法
Transfus Apher Sci. 2021 Feb;60(1):103018. doi: 10.1016/j.transci.2020.103018. Epub 2020 Nov 19.
4
Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.2019年冠状病毒病（COVID-19）抗体动力学对免疫及恢复期血浆治疗的影响
Clin Infect Dis. 2021 Aug 2;73(3):e540-e542. doi: 10.1093/cid/ciaa1213.
5
Covid-19 convalescent plasma and SARS-CoV-2 viral variants.新冠康复者血浆与严重急性呼吸综合征冠状病毒2病毒变体
Transfus Clin Biol. 2021 Aug;28(3):306. doi: 10.1016/j.tracli.2021.05.008. Epub 2021 May 29.
6
[Convalescent plasma therapy in COVID-19 patients].[新冠病毒肺炎患者的恢复期血浆治疗]
Medicina (B Aires). 2021;81(2):306.
7
Use of Convalescent Plasma in the Management of COVID-19.康复期血浆在新型冠状病毒肺炎治疗中的应用
Mo Med. 2021 Mar-Apr;118(2):118.
8
COVID-19 convalescent plasma therapy and immunodeficiency.新冠康复者血浆疗法与免疫缺陷
Transfus Clin Biol. 2021 Aug;28(3):306-307. doi: 10.1016/j.tracli.2021.05.007. Epub 2021 May 29.
9
Appropriate selection of convalescent plasma donors for COVID-19.为新冠病毒病（COVID-19）康复者血浆捐献者进行恰当选择。
Lancet Infect Dis. 2021 Feb;21(2):168-169. doi: 10.1016/S1473-3099(20)30470-9. Epub 2020 Jun 15.
10
[COVID-19: blood sufficiency versus convalescent plasma?].[新冠病毒肺炎：血液充足疗法与康复期血浆疗法？]
Rev Med Chil. 2020 Jun;148(6):721-723. doi: 10.4067/S0034-98872020000600721.
引用本文的文献
1
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients.从恢复期血浆治疗 COVID-19 中获得的经验教训以及免疫功能低下患者的具体注意事项。
Transfus Apher Sci. 2022 Jun;61(3):103355. doi: 10.1016/j.transci.2022.103355. Epub 2022 Jan 13.
2
Passive Immunity Should and Will Work for COVID-19 for Some Patients.被动免疫对一些新冠患者应该且将会起作用。
Clin Hematol Int. 2021 Apr 16;3(2):47-68. doi: 10.2991/chi.k.210328.001. eCollection 2021 Jun.
3
Effect of time and titer in convalescent plasma therapy for COVID-19.时间和滴度在COVID-19恢复期血浆治疗中的作用。
iScience. 2021 Aug 20;24(8):102898. doi: 10.1016/j.isci.2021.102898. Epub 2021 Jul 22.
4
Efficacy of convalescent plasma therapy in severe COVID-19 patients.恢复期血浆疗法治疗重症 COVID-19 患者的疗效。
Transfus Apher Sci. 2021 Aug;60(4):103158. doi: 10.1016/j.transci.2021.103158. Epub 2021 May 8.
5
Effects on mortality of early vs late administration of convalescent plasma in the treatment of Covid-19.新冠病毒感染患者中早期与晚期使用恢复期血浆治疗对死亡率的影响。
Transfus Apher Sci. 2021 Aug;60(4):103148. doi: 10.1016/j.transci.2021.103148. Epub 2021 Apr 24.
6
Effectiveness of convalescent plasma in Indian patients with COVID-19.恢复期血浆治疗 COVID-19 印度患者的效果。
Blood Cells Mol Dis. 2021 May;88:102548. doi: 10.1016/j.bcmd.2021.102548. Epub 2021 Feb 18.
7
Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies.恢复期血浆疗法治疗血液系统恶性肿瘤患者的严重 COVID-19。
Transfus Apher Sci. 2021 Jun;60(3):103075. doi: 10.1016/j.transci.2021.103075. Epub 2021 Feb 3.
8
Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19.用于传染病的恢复期血浆：历史框架及在COVID-19中的应用
Clin Microbiol Newsl. 2021 Feb 15;43(4):23-32. doi: 10.1016/j.clinmicnews.2021.02.001. Epub 2021 Feb 5.
9
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.恢复期血浆抗体水平与新冠死亡风险。
N Engl J Med. 2021 Mar 18;384(11):1015-1027. doi: 10.1056/NEJMoa2031893. Epub 2021 Jan 13.
10
Convalescent plasma (CP) therapy in patients with COVID-19.新冠病毒病患者的恢复期血浆疗法
Transfus Apher Sci. 2021 Feb;60(1):103018. doi: 10.1016/j.transci.2020.103018. Epub 2020 Nov 19.
本文引用的文献
1
Convalescent plasma (CP) therapy in patients with COVID-19.新冠病毒病患者的恢复期血浆疗法
Transfus Apher Sci. 2021 Feb;60(1):103018. doi: 10.1016/j.transci.2020.103018. Epub 2020 Nov 19.
2
The outcome of COVID-19 in patients with hematological malignancy.COVID-19 患者的血液恶性肿瘤结局。
J Med Virol. 2021 Feb;93(2):1099-1104. doi: 10.1002/jmv.26404. Epub 2020 Aug 26.
3
Convalescent plasma therapy in patients with COVID-19.新冠病毒肺炎患者的恢复期血浆治疗
J Clin Apher. 2020 Aug;35(4):367-373. doi: 10.1002/jca.21806. Epub 2020 Jul 9.
4
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件